SHR8735-303 A Randomized, Multi-Center, Double Blind, Phase III Study evaluating the efficacy and safety of Hetrombopag Olamine Tablets vs Placebo in patients with chemotherapy induced Thrombocytopenia.

by Mary Beth Wilwerding | Sep 2, 2026